04/21/2026
The most common question I get about medical weight loss: which one is better — semaglutide or tirzepatide?
And the honest answer is: it depends entirely on your body.
Semaglutide targets one hormone pathway — GLP-1. It slows gastric emptying, reduces appetite, and stabilizes blood sugar after meals. If your main challenge is appetite regulation and you want the medication with the longest clinical track record, this is usually where we start.
Tirzepatide targets two — GLP-1 and GIP together. That dual action does something semaglutide doesn’t: it also works on lipid metabolism and cellular energy expenditure. If you have insulin resistance, chronic inflammation, or a more complex metabolic history, that second pathway changes everything.
This is why I don’t do one-size-fits-all weight loss consults. I look at your metabolic baseline, your history, and your actual biology before I recommend anything. The goal is not the strongest medication. The goal is the most compatible one. Those are very different things.
Both guidelines include medical supervision, personalized dosing, and direct access to me. No vending machine medicine.
Sale pricing reflects medication cost. Your consult and labs are separate, and yes, we’ll walk you through all of it before you spend a dollar.
Link in bio to review and book your consult.
